Search

everythinglearnresearchcommunity

for

Search:↓

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Warfarin can rarely cause hair loss, which is usually reversible.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

High testosterone increases heart disease risk in women with PCOS.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Hair loss may indicate higher risk of heart disease.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Some families have a genetic condition where they are born with irregular scalp defects.

Understanding and tracking our body's natural daily rhythms could help improve heart health.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Looking at skin can help find and treat serious diseases early.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.